General Surgery Coding Alert - 2019 Issue 2
Modifiers: Get Familiar With Modifier JW Use in OPPS Settings
Subscribe or sign in to view the full article.
Article Overview
This premium article reviews Medicare guidance on modifier JW for reporting discarded drug and biological amounts in outpatient and hospital-based facility settings. It focuses on how the modifier is discussed by CMS, where it applies, where it does not apply, and how OPPS status indicators affect reporting. The article is intended for coders, billers, and revenue cycle staff who work with outpatient drug claims and need a practical overview of the policy landscape.
Why This Topic Matters
Accurate reporting of discarded drugs and biologicals affects claim completeness and compliance in outpatient and hospital-based settings. Understanding the differences among facility types and OPPS payment categories helps billing staff recognize when modifier JW is relevant.
Article Sections
-
Refresh Your Modifier JW Knowledge
Introduces CMS guidance on the modifier and its role in Medicare Part B drug claims. Provides a general overview of the policy framework for discarded amounts of drugs and biologicals.
-
Apply Modifier JW for Single-Use Vials, Packing
Discusses the types of drug packaging and labeling considerations associated with the modifier. Also touches on documentation and facility supply distinctions.
-
Know When Not to Append JW
Covers situations and facility settings where the modifier is not used, along with references to Medicare manual guidance. Includes broader discussion of reporting contexts such as outpatient and inpatient claim environments.
-
Factor in OPPS Status Indicators
Reviews how OPPS status indicators relate to separately payable drugs and packaged items. Explains that facility reporting considerations vary based on the payment category.
-
Consider This Modifier JW Example
Presents an illustrative outpatient drug reporting scenario tied to modifier use and line-level claim reporting. The example shows how the article applies the broader guidance in practice.
What You Will Learn
- How CMS frames modifier JW in Medicare Part B drug claims
- Which outpatient and hospital-based settings are discussed in relation to discarded drugs and biologicals
- How OPPS status indicators relate to reporting considerations for discarded drug amounts
- What kinds of facility and documentation factors are highlighted in the article
- How the article uses an example to illustrate outpatient drug reporting concepts
Who Should Read This
- Medical coders
- Outpatient facility billers
- Hospital revenue cycle staff
- Compliance staff
- Medicare claims professionals
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com